Drugs / GC3111B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06997627 | Jun 2025 → May 2026 overdue | — | GC Biopharma Corp | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GC3111B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06997627 ↗ |
| Modality | Vaccine | “Participants randomized to receive a single dose of GC3111B vaccine.” NCT06997627 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular injection” NCT06997627 ↗ |